Outcomes after a 1-Year Treatment with Ranibizumab for Diabetic Macular Edema in a Clinical Setting

Publisher： Karger

E-ISSN： 1423-0267|236|4|207-214

ISSN： 0030-3755

Source： Ophthalmologica, Vol.236, Iss.4, 2016-11, pp. : 207-214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Macular Ischemia on Intravitreal Ranibizumab Treatment for Diabetic Macular Edema

By  

Ophthalmologica, Vol. 232, Iss. 3, 2014-08 ,pp. : 136-143

Karger

Access to resources Recommend Favorite

Intravitreal Ranibizumab (Lucentis) for the Treatment of Diabetic Macular Edema: A Systematic Review and Meta-Analysis of Randomized Clinical Control Trials

By Wang Haiyan   Sun Xiaodong   Liu Kun   Xu Xun  

Current Eye Research, Vol. 37, Iss. 8, 2012-08 ,pp. : 661-670

Informa Healthcare

Access to resources Recommend Favorite

Dexamethasone Implant in Chronic Diabetic Macular Edema Resistant to Intravitreal Ranibizumab Treatment

By  

Ophthalmic Research, Vol. 57, Iss. 3, 2016-12 ,pp. : 161-165

Karger

Access to resources Recommend Favorite

Early Response to Ranibizumab Is Associated with 12-Month Outcome in Diabetic Macular Edema after Prior Macular Laser Therapy

By  

Ophthalmologica, Vol. 238, Iss. 3, 2017-07 ,pp. : 139-146

Karger

Access to resources Recommend Favorite

Comment on the Paper by Douvali et al. Entitled ‘Effect of Macular Ischemia on Intravitreal Ranibizumab Treatment for Diabetic Macular Edema'

By  

Ophthalmologica, Vol. 233, Iss. 2, 2014-12 ,pp. : 115-115

Karger

Access to resources Recommend Favorite